Picture this. Your innovation team has spent nine months developing a new product. The concept is solid, consumer research looks promising, and the launch plan is ready. Then, three weeks before market entry, your procurement team tells you the key ingredient has doubled in price. The margins no longer work. The product either launches at a loss, gets shelved, or launches with a reformulation that was never tested with consumers.
This is not a hypothetical. For hundreds of FMCG companies over the past two years, it has been Tuesday.
Feasibility is no longer a checklist item at the end of development. It is the starting point.
Cocoa prices surged 177% in 2024, reaching an all-time high of over $12,500 per metric ton, driven by back-to-back harvest failures in the Ivory Coast and Ghana, which together supply 60% of the world’s cocoa. Coffee hit a 47-year price high in early 2025, with Arabica futures surging past $4 per pound, roughly a 79% increase year-on-year. These are not blips. They are the new operating reality.
Sources: Confectionery News, January 2025
And yet, most FMCG innovation processes were not built for this world. They were built for a world where ingredient costs were broadly stable, supply chains were predictable, and feasibility was something you checked near the end of development, not at the beginning. That world is gone.
THE FAILURE RATE THAT NOBODY TALKS ABOUT LOUDLY ENOUGH
Before getting to what needs to change, it is worth sitting with the baseline. More than 80% of new FMCG products fail commercially, according to analysis from Nielsen and NielsenIQ. Some estimates put the figure higher still: Nielsen’s own research found that 85% of new consumer packaged goods do not sustain commercial viability beyond the launch phase. Catalina’s study on new food and beverage products found that only 11% of first-time buyers remained engaged after one year.
Sources: NielsenIQ, The Value of Failures in FMCG
That number has stayed stubbornly high for decades. But something has changed. In a stable commodity environment, a product that failed commercially was expensive but recoverable. You learned, you iterated, you tried again. In a volatile commodity environment, a product that fails commercially and was built around an ingredient that has since been repriced by triple digits is a different kind of problem entirely. It is not just a failed launch. It is a failed bet on a cost structure that no longer exists.
85% of new FMCG products fail. In a volatile ingredient market, that failure is no longer just expensive. It is compounding.
WHAT FEASIBILITY-FIRST INNOVATION ACTUALLY MEANS
The shift that leading FMCG companies are making is not about slowing down innovation. It is about changing where the hard questions get asked. According to Euromonitor’s April 2026 analysis of competitive FMCG strategy, feasibility is moving upstream: shaping ingredient selection, formulation design, and portfolio strategy from the very start of development, not as a gate at the end.
In practice, this means three things. First, ingredient viability has to be assessed at the concept stage, not the development stage. If your hero ingredient is sourced from a region facing climate disruption, or is concentrated in a handful of suppliers, that is a strategic risk that belongs on the innovation brief, not the procurement report.
Second, portfolio fit has to be evaluated earlier. A new product that cannibalizes an existing SKU, strains shared manufacturing capacity, or creates a supply chain dependency that the business cannot absorb is not an innovation. It is a liability with packaging.
Third, the innovation process itself needs to carry financial stress-testing as a built-in checkpoint, not an afterthought. The companies that weathered the cocoa crisis best were the ones that had already modelled what a 50%, 100%, or 150% price shock would do to each product in their pipeline. Those that had not were the ones reformulating under pressure, dropping chocolate labelling from established products, or absorbing margin hits that took years to recover.
The companies that weathered the cocoa crisis best had already stress-tested their pipelines for a 100% price shock. Most had not.
SPEED IS NOT THE PROBLEM. STRUCTURE IS.
There is a common assumption in FMCG that the solution to high failure rates is faster iteration: launch more, test more, learn more quickly. That logic made sense when the main variable was consumer preference. When ingredient costs, supply chain resilience, and regulatory compliance are equally live variables, speed without structure does not reduce risk. It multiplies it.
According to the 2026 FMCG and Chemicals Industry Outlook by Pacific International, the companies outperforming in this environment share a common trait: clear portfolio strategies and decisive leadership. Not faster pipelines, but more disciplined ones. Margin discipline, brand differentiation, and innovation speed have become more important than sheer scale.
Source: Pacific International, 2026 Industry Outlook: FMCG, Chemicals and Process Industries, February 2026
Structure, in this context, means having a process that forces the right questions at the right time. It means gate reviews where feasibility, not just consumer appeal, is a pass criterion. It means portfolio simulation that models the downstream impact of launching, shelving, or modifying a product before the decision is made. It means connecting the innovation pipeline to real-world cost and supply data, not just internal R&D assumptions.
This is exactly the gap that structured innovation management platforms are designed to close. When your process model includes financial stress tests and ingredient risk flags at every gate, feasibility stops being a last-minute obstacle and becomes a built-in lens that shapes every decision from concept to launch.
THE STRATEGIC REFRAME
Here is the reframe that the most competitive FMCG companies are making right now. Innovation success is not just about whether consumers love the product. It is about whether the product can be made profitably, consistently, and at scale, across a range of scenarios that include supply shocks, regulatory changes, and competitive responses.
A product that scores brilliantly in consumer testing but depends on a single-origin ingredient from a climate-vulnerable region is not a strong innovation. It is a fragile one. And in 2026, fragile innovations are the ones that consume the most resources, damage the most teams, and produce the least return.
A product that consumers love but cannot be made profitably at scale is not an innovation. It is a liability with good branding.
The market is beginning to price this in. According to McKinsey’s State of Food and Beverage survey of 15,000 consumers, about two-thirds globally say they would pay 10% or more for a healthier alternative to their usual snack, pushing brands to reformulate with cleaner ingredients and more transparent labelling. That is a consumer pull towards ingredient scrutiny, which aligns directly with the business imperative to build supply chain resilience into innovation from the start.
Source: McKinsey, State of Food and Beverage, 2026
The companies that will lead their categories in the next five years are not necessarily the ones with the most creative R&D teams. They are the ones that have built innovation systems robust enough to generate good ideas and disciplined enough to stress-test them against the world as it actually is.
THE BOTTOM LINE
The FMCG industry has always been competitive. What has changed is the nature of the risk. For most of the last three decades, the primary innovation risk was consumer rejection. Today, the risk surface is wider: ingredient volatility, supply chain concentration, sustainability compliance, and retailer margin pressure are all live variables that can invalidate a product before it reaches the shelf.
Running a product development process that only asks feasibility questions at the end is like designing a building without a structural engineer and hoping the architect got it right. Sometimes it works. More often, it does not.
The companies building the strongest FMCG portfolios in 2026 are not asking feasibility questions last. They are asking them first, throughout, and with real data. That is not slower innovation. That is smarter innovation.
And in this market, smarter is the only kind that survives.
